Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cerebral Glioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00002824
What this trial is testing

Gene Therapy in Treating Patients With Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Abramson Cancer Center at Penn Medicine
Early research (Phase 1)Study completedNCT00272350
What this trial is testing

ZD6474 to Treat Advanced Brain Cancer in Patients

Who this might be right for
Recurrent High-Grade GliomasProgressive Low-Grade GliomasMalignant Gliomas
National Cancer Institute (NCI) 83
Testing effectiveness (Phase 2)WithdrawnNCT00053040
What this trial is testing

Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium
Early research (Phase 1)Active Not RecruitingNCT03500991
What this trial is testing

HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors

Who this might be right for
Central Nervous System Tumor, PediatricGliomaEpendymoma+6 more
Seattle Children's Hospital 10
Not applicableUnknownNCT01317888
What this trial is testing

Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade Gliomas

Who this might be right for
Glioblastoma MultiformeAstrocytoma Anaplastic Foci
Drexel University 11
Testing effectiveness (Phase 2)Study completedNCT00087061
What this trial is testing

Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Early research (Phase 1)UnknownNCT02149459
What this trial is testing

Treatment of Recurrent Brain Tumors: Metabolic Manipulation Combined With Radiotherapy

Who this might be right for
Brain Neoplasms
Sheba Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT01977677
What this trial is testing

Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma

Who this might be right for
Adult EpendymoblastomaAdult Giant Cell GlioblastomaAdult Glioblastoma+6 more
Lawrence Recht 30
Not applicableAvailableNCT07748299
What this trial is testing

NuvOx Expanded Access

Who this might be right for
GlioblastomaRespiratory Distress SyndromIschemic Stroke+1 more
NuvOx LLC
Testing effectiveness (Phase 2)Active Not RecruitingNCT05859334
What this trial is testing

Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment

Who this might be right for
Recurrent GliomaRecurrent WHO Grade 2 GliomaRecurrent WHO Grade 3 Glioma+1 more
National Cancer Institute (NCI) 30
Very early researchActive Not RecruitingNCT05634707
What this trial is testing

Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)

Who this might be right for
Primary Brain TumorBrain Tumor, Recurrent
Duke University 10
Not applicableStudy completedNCT02849171
What this trial is testing

Assessing 11C-Choline (11C-CH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade Gliomas

Who this might be right for
Brain Cancer
Memorial Sloan Kettering Cancer Center 8
Not applicableStudy completedNCT02303938
What this trial is testing

Effects of Exercise on Cognitive Function in Glioma Patients

Who this might be right for
Low Grade Glioma of BrainAnaplastic Glioma of Brain
Tilburg University 60
Testing effectiveness (Phase 2)Ended earlyNCT00479765
What this trial is testing

/ 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma

Who this might be right for
Glioblastoma MultiformeBrain Neoplasms
Boston Scientific Corporation 4
Not applicableLooking for participantsNCT07831772
What this trial is testing

REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaNewly Diagnosed GlioblastomaBrain Tumor
University of Minnesota 4
Early research (Phase 1)Study completedNCT01158300
What this trial is testing

PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 28
Early research (Phase 1)Ended earlyNCT01269411
What this trial is testing

RO4929097 in Treating Patients With Recurrent Invasive Gliomas

Who this might be right for
Adult Anaplastic OligodendrogliomaAdult Brain Stem GliomaAdult Giant Cell Glioblastoma+4 more
National Cancer Institute (NCI) 22
Not applicableWithdrawnNCT00985036
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients

Who this might be right for
GliomaMeningioma
Marquette General Health System
Large-scale testing (Phase 3)Study completedNCT00154375
What this trial is testing

Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma

Who this might be right for
Glioblastoma MultiformeAstrocytoma
Novartis Pharmaceuticals 240
Testing effectiveness (Phase 2)Study completedNCT00093964
What this trial is testing

Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)

Who this might be right for
Glioblastoma Multiforme
EMD Serono 81
Next Page